Explore how the FDA distinguishes between standard (10-month) and priority (8-month) review timelines for generic drug applications. Learn about GDUFA III rules, the new U.S. manufacturing pilot program, and strategies to avoid delays.
Explore how the FDA distinguishes between standard (10-month) and priority (8-month) review timelines for generic drug applications. Learn about GDUFA III rules, the new U.S. manufacturing pilot program, and strategies to avoid delays.